December 2017

Fusion Antibodies gears up for flotation on the AIM

Uncategorised / admin

The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

Fusion Antibodies gears up for flotation on the AIM Read More »

AuditComply to use Kx technology and BGF equity to drive sales

Uncategorised / admin

AuditComply, a CoFund portfolio company, has become the first business to benefit from technology and investment.

AuditComply to use Kx technology and BGF equity to drive sales Read More »

PathXL doubles its employees under new ownership

Uncategorised / admin

The Belfast Telegraph has reported that PathXL, a former CoFund portfolio company, plans to double its workforce.

PathXL doubles its employees under new ownership Read More »

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

December 2017

Fusion Antibodies gears up for flotation on the AIM

AuditComply to use Kx technology and BGF equity to drive sales

PathXL doubles its employees under new ownership

ABOUT US

ADDITIONAL LINKS